FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adul... (conform them to future events or develop...)

HOME >> MEDICINE >> NEWS

FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia

Date:9/22/2007

conform them to future events or developments

Genzyme Contacts: Bayer Contacts:

Maria Cantor (media) Kimberly Wix (media)

(617) 768-6690 (973) 305-5258

Sally Curley (investors) Jost Reinhard (ex-US media)

(617) 768-6140 +49-30-468-15062

SOURCE Genzyme Corp. and Bayer HealthCare Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. FDA approves Phase 0 trial which tests experimental drugs on humans
2. FDA Approves Contraceptive Ring
3. FDA approves new device to treat womens bleeding disorder
4. FDA Approves New HIV Drug, Viread
5. FDA Approves Birth Control Skin Patch
6. FDA approves surgical gel
7. FDA Approves New Arthritis Drug, Bextra
8. FDA Approves Elidel Cream for Eczema
9. FDA approves drug for rare liver disease
10. FDA approves first pocket-sized EKG machine
11. FDA Approves New Anti-Clotting Drug

Post Your Comments:

(Date:5/12/2008)...n-compliance with California Environmental ...S, May 12 /PRNewswire-USNewswire/ -- Providence Ho...ith the planned expansion of its,Holy Cross Medica...Knew,Jr. has upheld charges that the approval pro...ceremony held today appears to be an attempt to cr...

(Date:5/12/2008)...e-FirstCall/ - Med-Emerg International Inc.,(OTCBB...uing operations,for the three months ended March ...n for the same period in 2007 (all amounts are $US...iod, earnings before,depreciation, amortization, i...a loss of ($106K) in 2007. The improvement in EBIT...

(Date:5/12/2008)...RNewswire-FirstCall/ -- (Nasdaq: WHRT, TSX:,WHT) W...ration") announced,that the Toronto Stock Exchange...viewing the eligibility for continued listing on t...ctions 709 and 710(a) of the TSX Company,Manual. T...ition and,operating results, more specifically whe...

(Date:5/12/2008).../PRNewswire/ -- Keck Graduate Institute (KGI),toda...remony will feature,the graduation of KGI,s first ...d the unveiling of KGI,s first donated artwork., ...nt in becoming the,first graduate of our new PhD p...president for academic affairs, dean of faculty an...

Breaking Medicine News(10 mins):Health News:Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility 2 Health News:Med-Emerg International Inc. reports improved income from continuing operations 2 Health News:Med-Emerg International Inc. reports improved income from continuing operations 3 Health News:WorldHeart Notified of TSX Delisting Review 2 Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2

[0] Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility [0] Med-Emerg International Inc. reports improved income from continuing operations [0] WorldHeart Notified of TSX Delisting Review [0] KGI 2008 Commencement Features First PhD Graduate, Biotech Painting

...st that can detect non-small cell lung cancer (NSC... University of Kentucky. The test is highly accura...several years before they are identified by advanc...ided to partner with 20/20 GeneSystems Inc for the...

...vices in Australia’s Townsville will be revolution...given to the James Cook University (JCU).// A rura...bbott, the Health Minister, at JCU. The University...students to study in Atherton, Cairns, and Mackay....

...ords Science and Technology Committee has issued a...ritain, there would be a severe shortage of food. ...up efforts to collaborate on an international leve...re alternative plans to combat an epidemic should ...

...ated to Food science and consumer acceptance in No...s react differently then do experts to cheese.// T...nsumers were compared with expert dairy assessors....eaction of consumers and quality scores by experts...

Other Medicine News:

New Test For Early Detection of Non-Small Cell Lung Cancer JCU Gets A$ 3 million Government Funding UK Committee Warns on Food Shortages Due to Flu Epidemic A cheesy story!!!

(Date:5/12/2008)...A, May 12 /- GeoVax Labs, I...HIV/AIDS vaccine development,company, announced to...stock purchase agreement with Fusion Capital Fund ... The Company may sell up to $10 million of its com... a 25-month period after the Securities and,Exchan...

(Date:5/12/2008)...es the Optimal Combination of Scaffolding, Deliver...lity, TEL AVIV, Israel, May 12 /- Me... Mark for its Presillion(TM) CoCr Coronary Stent,...ns with a technologically,innovative flexible clos...he superb scaffolding the unprecedented,balance of...

(Date:5/12/2008)...ELPHIA, May 12 /PRNewswire-USNewswire/ -- GlaxoSmi...ternational Group (BIG), a leading,academic breast...oups, the,Spanish Breast Cancer Cooperative Group ...se III study that will examine the role of TYKERB(...TTO (Neoadjuvant Lapatinib and/or,Trastuzumab Trea...

(Date:5/9/2008)...Fla., May 9 /PRNewswire-USNewswire/ -- Osteoarthri...ition that affects almost 50,million people in the...artilage in bone joints. The novel investigational...al analgesic, provided significant relief,for pati...eated with,placebo, and with fewer gastrointestina...

Breaking Medicine Technology:GeoVax Secures $10 Million Financing Commitment 2 GeoVax Secures $10 Million Financing Commitment 3 Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents 2 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7 Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2 Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3 Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4 Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5 Mayor Bloomberg Declares March 6 2008 World Glaucoma Day in New York City 12887 1 Mayor Bloomberg Declares March 6 2008 World Glaucoma Day in New York City 12887 2 Medication Management Systems Names New President and COO 12883 1 Medication Management Systems Names New President and COO 12883 2 Alzheimers Foundation of America Awards Grants to Local Groups Nationwide 12878 1 Alzheimers Foundation of America Awards Grants to Local Groups Nationwide 12878 2 Bacteria beware 3A MIT student invents knock out punch for antibiotic resistance 12875 1 Bacteria beware 3A MIT student invents knock out punch for antibiotic resistance 12875 2 Bacteria beware 3A MIT student invents knock out punch for antibiotic resistance 12875 3 Bacteria beware 3A MIT student invents knock out punch for antibiotic resistance 12875 4

[0] GeoVax Secures $10 Million Financing Commitment [0] Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents [0] TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial [0] Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile

...NGLE PARK, N.C. & SHERBROOKE, Quebec--(BUSINES... biopharmaceutical,company developing small molecu... metabolic diseases, today announced positive,resu...elerating,gastric emptying in diabetic patients wi...study were presented at the American,Diabetes Asso...

...INESS WIRE)--Jun 25, 2007 - New data from an,inves... Association,(ADA) 67th Annual Scientific Sessions...via(TM) (sitagliptin) and metformin,demonstrated s...ction in patients with type 2 diabetes. Pancreatic...f the body to produce,insulin, a hormone which pla...

Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes

...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...

Medicine Products:

Cytomegalovirus Antibody, IgM Cytology, Vitreous Fluid Cytology, Urologic Cytology, ThinPrep Pap Test

FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adul...(conform them to future events or develop...),Health